Jane Street
VTVT icon

Jane Street’s vTv Therapeutics VTVT Stock Holding History

Jane Street’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$516K Buy
+13,703
New +$475K ﹤0.01% 7939
2022
Q1 		– Sell
-349
Closed -$14K – 11093
2021
Q4 		$14K Buy
+349
New +$18.7K ﹤0.01% 9863
2021
Q3 		– Sell
-1,832
Closed -$167K – 10814
2021
Q2 		$167K Buy
+1,832
New +$186K ﹤0.01% 8961
2020
Q4 		– Sell
-395
Closed -$28K – 8177
2020
Q3 		$28K Sell
395
-163
-29% -$14.3K ﹤0.01% 7004
2020
Q2 		$50K Buy
+558
New +$55.1K ﹤0.01% 6867
2018
Q3 		– Sell
-622
Closed -$38K – 5767
2018
Q2 		$38K Buy
+622
New +$45.9K ﹤0.01% 4838

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's VTVT Position: Q2 2026 in Review

Jane Street opened a new position in vTv Therapeutics (VTVT) in Q2 2026: 13,703 shares worth $516K. The stake represents ﹤0.01% of the portfolio and ranks #7939 among its holdings. This is a return to the name: Jane Street previously reported a position in VTVT as recently as Q4 2021.

Jane Street first reported a position in VTVT in Q2 2018 and has held it in 6 quarters since. 45 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Jane Street held 13,703 shares of vTv Therapeutics worth $516K as of Q2 2026.
  • vTv Therapeutics was a new Jane Street position in Q2 2026.
  • vTv Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7939 holding.
  • Jane Street first reported a position in vTv Therapeutics in Q2 2018 and has held it in 6 quarters since.
  • 45 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.